Royal Bank of Canada’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2K | Sell |
564
-4,429
| -89% | -$23.1K | ﹤0.01% | 6727 |
|
|
2025
Q4 | $31K | Buy |
4,993
+2,818
| +130% | +$20.4K | ﹤0.01% | 5815 |
|
|
2025
Q3 | $16K | Sell |
2,175
-16,173
| -88% | -$96K | ﹤0.01% | 6313 |
|
|
2025
Q2 | $97K | Sell |
18,348
-14,978
| -45% | -$88.5K | ﹤0.01% | 5628 |
|
|
2025
Q1 | $296K | Buy |
33,326
+15,057
| +82% | +$181K | ﹤0.01% | 4405 |
|
|
2024
Q4 | $250K | Buy |
18,269
+1,956
| +12% | +$36.1K | ﹤0.01% | 4625 |
|
|
2024
Q3 | $448K | Sell |
16,313
-44
| -0.3% | -$1.19K | ﹤0.01% | 4184 |
|
|
2024
Q2 | $400K | Buy |
16,357
+7,319
| +81% | +$161K | ﹤0.01% | 4183 |
|
|
2024
Q1 | $193K | Sell |
9,038
-6,681
| -43% | -$144K | ﹤0.01% | 4721 |
|
|
2023
Q4 | $301K | Buy |
15,719
+7,453
| +90% | +$129K | ﹤0.01% | 4727 |
|
|
2023
Q3 | $133K | Buy |
8,266
+6,997
| +551% | +$133K | ﹤0.01% | 5159 |
|
|
2023
Q2 | $30K | Sell |
1,269
-7,658
| -86% | -$167K | ﹤0.01% | 6012 |
|
|
2023
Q1 | $208K | Sell |
8,927
-9,835
| -52% | -$200K | ﹤0.01% | 4597 |
|
|
2022
Q4 | $273K | Buy |
18,762
+16,423
| +702% | +$306K | ﹤0.01% | 4615 |
|
|
2022
Q3 | $44K | Buy |
2,339
+526
| +29% | +$12.1K | ﹤0.01% | 5798 |
|
|
2022
Q2 | $33K | Sell |
1,813
-4,036
| -69% | -$83.8K | ﹤0.01% | 5897 |
|
|
2022
Q1 | $148K | Sell |
5,849
-9,122
| -61% | -$233K | ﹤0.01% | 5355 |
|
|
2021
Q4 | $412K | Buy |
14,971
+4,101
| +38% | +$119K | ﹤0.01% | 4647 |
|
|
2021
Q3 | $352K | Buy |
10,870
+3,879
| +55% | +$129K | ﹤0.01% | 4646 |
|
|
2021
Q2 | $213K | Buy |
6,991
+3,138
| +81% | +$90.7K | ﹤0.01% | 5025 |
|
|
2021
Q1 | $117K | Sell |
3,853
-22,880
| -86% | -$649K | ﹤0.01% | 5347 |
|
|
2020
Q4 | $529K | Buy |
26,733
+1,589
| +6% | +$25.7K | ﹤0.01% | 4087 |
|
|
2020
Q3 | $328K | Buy |
25,144
+2,784
| +12% | +$35.2K | ﹤0.01% | 4195 |
|
|
2020
Q2 | $253K | Sell |
22,360
-2,898
| -11% | -$41.2K | ﹤0.01% | 4283 |
|
|
2020
Q1 | $361K | Buy |
25,258
+13,254
| +110% | +$280K | ﹤0.01% | 3899 |
|
|
2019
Q4 | $327K | Buy |
12,004
+8,394
| +233% | +$231K | ﹤0.01% | 4276 |
|
|
2019
Q3 | $103K | Sell |
3,610
-9,619
| -73% | -$280K | ﹤0.01% | 4789 |
|
|
2019
Q2 | $368K | Buy |
13,229
+8,767
| +196% | +$248K | ﹤0.01% | 4060 |
|
|
2019
Q1 | $148K | Buy |
4,462
+612
| +16% | +$18.6K | ﹤0.01% | 4531 |
|
|
2018
Q4 | $112K | Sell |
3,850
-173,571
| -98% | -$6.24M | ﹤0.01% | 4667 |
|
|
2018
Q3 | $8.16M | Buy |
177,421
+166,131
| +1,471% | +$7.39M | ﹤0.01% | 1746 |
|
|
2018
Q2 | $421K | Buy |
11,290
+6,693
| +146% | +$226K | ﹤0.01% | 3912 |
|
|
2018
Q1 | $136K | Buy |
4,597
+1,715
| +60% | +$58K | ﹤0.01% | 4525 |
|
|
2017
Q4 | $99K | Sell |
2,882
-6,343
| -69% | -$214K | ﹤0.01% | 4822 |
|
|
2017
Q3 | $334K | Buy |
9,225
+4,365
| +90% | +$125K | ﹤0.01% | 4122 |
|
|
2017
Q2 | $125K | Sell |
4,860
-7,362
| -60% | -$156K | ﹤0.01% | 4641 |
|
|
2017
Q1 | $235K | Buy |
12,222
+1,583
| +15% | +$28K | ﹤0.01% | 4240 |
|
|
2016
Q4 | $177K | Buy |
10,639
+5,521
| +108% | +$99.9K | ﹤0.01% | 4560 |
|
|
2016
Q3 | $106K | Sell |
5,118
-5,313
| -51% | -$135K | ﹤0.01% | 4792 |
|
|
2016
Q2 | $321K | Buy |
10,431
+1,851
| +22% | +$64.3K | ﹤0.01% | 4045 |
|
|
2016
Q1 | $322K | Sell |
8,580
-18,889
| -69% | -$712K | ﹤0.01% | 4004 |
|
|
2015
Q4 | $1.19M | Buy |
27,469
+12,325
| +81% | +$521K | ﹤0.01% | 2975 |
|
|
2015
Q3 | $567K | Sell |
15,144
-8,283
| -35% | -$294K | ﹤0.01% | 3384 |
|
|
2015
Q2 | $796K | Sell |
23,427
-3,793
| -14% | -$129K | ﹤0.01% | 3129 |
|
|
2015
Q1 | $963K | Sell |
27,220
-8,170
| -23% | -$292K | ﹤0.01% | 2914 |
|
|
2014
Q4 | $1.21M | Sell |
35,390
-25,566
| -42% | -$907K | ﹤0.01% | 2766 |
|
|
2014
Q3 | $2.35M | Sell |
60,956
-31,695
| -34% | -$1.18M | ﹤0.01% | 2181 |
|
|
2014
Q2 | $3.61M | Buy |
92,651
+1,126
| +1% | +$41.9K | ﹤0.01% | 1870 |
|
|
2014
Q1 | $3.13M | Sell |
91,525
-145,896
| -61% | -$4.52M | ﹤0.01% | 1926 |
|
|
2013
Q4 | $4.98M | Buy |
237,421
+187,470
| +375% | +$4.74M | ﹤0.01% | 1662 |
|
|
2013
Q3 | $1.17M | Buy |
49,951
+10,437
| +26% | +$297K | ﹤0.01% | 2623 |
|
|
2013
Q2 | $1.06M | Buy |
+39,514
| New | +$1.15M | ﹤0.01% | 2522 |
|
Other funds holding MYGN
O
GCM
VCM
VPM
Royal Bank of Canada's MYGN Position: Q1 2026 in Review
Royal Bank of Canada reduced its Myriad Genetics (MYGN) stake by 89% in Q1 2026, selling an estimated $23.1K and leaving 564 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #6727.
Royal Bank of Canada first reported a position in MYGN in Q2 2013 and has held it in 52 quarters since. The position peaked at $8.16M in Q3 2018. 202 funds tracked by Wall St. Rank hold MYGN as of Q1 2026.
- Royal Bank of Canada held 564 shares of Myriad Genetics worth $2K as of Q1 2026.
- Royal Bank of Canada sold 4,429 Myriad Genetics shares in Q1 2026, an estimated $23.1K.
- Myriad Genetics made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #6727 holding.
- Royal Bank of Canada first reported a position in Myriad Genetics in Q2 2013 and has held it in 52 quarters since.
- Royal Bank of Canada's Myriad Genetics position peaked at $8.16M in Q3 2018.
- 202 funds tracked by Wall St. Rank held Myriad Genetics as of Q1 2026.
Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.